Tuberculosis reactivation risk in patients treated with tumor necrosis factor alpha inhibitors: a turkish experience with higher mortality and different background diseases.
dc.contributor.author | Kısacık, Bünyamin | |
dc.contributor.author | Pamuk, Ömer | |
dc.contributor.author | Onat, Ahmet Mesut | |
dc.contributor.author | Erer, Burak | |
dc.contributor.author | Hatemi, Gülen | |
dc.contributor.author | Özgüler, Yeşim | |
dc.contributor.author | Kılıç, Levent | |
dc.contributor.author | Ertenli, İhsan | |
dc.contributor.author | Can, Meryem | |
dc.contributor.author | Direskeneli, Haner | |
dc.contributor.author | Keser, Gökhan | |
dc.contributor.author | Öksel, Fahrettin | |
dc.contributor.author | Yılmaz, Sedat | |
dc.contributor.author | Pay, Salih | |
dc.contributor.author | Balkarlı, Ayşe | |
dc.contributor.author | Çobankara, Veli | |
dc.contributor.author | Çetin, Gözde Yıldırım | |
dc.contributor.author | Sayarlıoğlu, Mehmet | |
dc.contributor.author | Cefle, Ayşe | |
dc.contributor.author | Yazıcı, Ayten | |
dc.contributor.author | Avcı, Ali Berkant | |
dc.contributor.author | Terzioğlu, Ender | |
dc.contributor.author | Özbek, Süleyman | |
dc.contributor.author | Akar, Servet | |
dc.contributor.author | Gül, Ahmet | |
dc.contributor.buuauthor | Pehlivan, Yavuz | |
dc.contributor.buuauthor | Dalkılıç, Ediz | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi. | tr_TR |
dc.contributor.researcherid | AAG-8227-2021 | tr_TR |
dc.date.accessioned | 2024-02-05T06:28:38Z | |
dc.date.available | 2024-02-05T06:28:38Z | |
dc.date.issued | 2014-10 | |
dc.identifier.citation | Pehlivan, Y. vd. (2014). "Tuberculosis reactivation risk in patients treated with tumor necrosis factor alpha inhibitors: A turkish experience with higher mortality and different background diseases.". Arthritis & Rheumatology, Supplement: 10, Special Issue: SI, Meeting Abstract: 2157, 66, S943-S943. | en_US |
dc.identifier.endpage | S943 | tr_TR |
dc.identifier.issn | 2326-5191 | |
dc.identifier.issn | 2326-5205 | |
dc.identifier.startpage | S943 | tr_TR |
dc.identifier.uri | https://hdl.handle.net/11452/39489 | |
dc.identifier.volume | 66 | tr_TR |
dc.identifier.wos | 000344384904305 | tr_TR |
dc.indexed.pubmed | PubMed | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.wos | CPCIS | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.relation.collaboration | Yurt içi | tr_TR |
dc.relation.collaboration | Sanayi | tr_TR |
dc.relation.ispartofseries | ||
dc.relation.journal | Arthritis & Rheumatology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject.wos | Rheumatology | en_US |
dc.title | Tuberculosis reactivation risk in patients treated with tumor necrosis factor alpha inhibitors: a turkish experience with higher mortality and different background diseases. | en_US |
dc.type | Article | en_US |
dc.wos.quartile | Q4 (Rheumatology) | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: